prikaz prve stranice dokumenta Green solvent-free synthesis of new N-heterocycle-L-ascorbic acid hybrids and their antiproliferative evaluation
  Download
PDF 1.91 MB
Scientific paper - Original scientific paper
Green solvent-free synthesis of new N-heterocycle-L-ascorbic acid hybrids and their antiproliferative evaluation
Future Med. Chem., 14 (2022), 16; 1187-1202. https://doi.org/10.4155/fmc-2022-0047
Bistrović Popov, Andrea; Meščić Macan, Andrijana; Jakopec, Silvio; Prpi´c, Helena; Harej Hrkać, Anja; Kraljeviić Pavelić, Sandra; Raić-Malić, Silvana

Cite this document

Bistrović Popov, A., Meščić Macan, A., Jakopec, S., Prpi´c, H., Harej Hrkać, A., Kraljeviić Pavelić, S. & Raić Malić, S. (2022). Green solvent-free synthesis of new N-heterocycle-L-ascorbic acid hybrids and their antiproliferative evaluation. Future Med. Chem., 14. (16), 1187-1202. doi: 10.4155/fmc-2022-0047

Bistrović Popov, Andrea, et al. "Green solvent-free synthesis of new N-heterocycle-L-ascorbic acid hybrids and their antiproliferative evaluation." Future Med. Chem., vol. 14, no. 16, 2022, pp. 1187-1202. https://doi.org/10.4155/fmc-2022-0047

Bistrović Popov, Andrea, Andrijana Meščić Macan, Silvio Jakopec, Helena Prpi´c, Anja Harej Hrkać, Sandra Kraljeviić Pavelić and Silvana Raić Malić. "Green solvent-free synthesis of new N-heterocycle-L-ascorbic acid hybrids and their antiproliferative evaluation." Future Med. Chem. 14, no. 16 (2022): 1187-1202. https://doi.org/10.4155/fmc-2022-0047

Bistrović Popov, A., et al. (2022) 'Green solvent-free synthesis of new N-heterocycle-L-ascorbic acid hybrids and their antiproliferative evaluation', Future Med. Chem., 14(16), pp. 1187-1202. doi: 10.4155/fmc-2022-0047

Bistrović Popov A, Meščić Macan A, Jakopec S, Prpi´c H, Harej Hrkać A, Kraljeviić Pavelić S, and sur.. Green solvent-free synthesis of new N-heterocycle-L-ascorbic acid hybrids and their antiproliferative evaluation. Future Med. Chem. [Internet]. 2022 [cited 2024 May 05];14(16):1187-1202. doi: 10.4155/fmc-2022-0047

A. Bistrović Popov, et al., "Green solvent-free synthesis of new N-heterocycle-L-ascorbic acid hybrids and their antiproliferative evaluation", Future Med. Chem., vol. 14, no. 16, pp. 1187-1202, 2022. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:144906. [Accessed: 05 May 2024]

Please login to the repository to save this object to your list.
Metadata
Title (english)Green solvent-free synthesis of new N-heterocycle-L-ascorbic acid hybrids and their antiproliferative evaluation
AuthorAndrea Bistrović Popov
AuthorAndrijana Meščić Macan
AuthorSilvio Jakopec
AuthorHelena Prpi´c
AuthorAnja Harej Hrkać
AuthorSandra Kraljeviić Pavelić
AuthorSilvana Raić-Malić
Author's institutionUniversity of Rijeka
Faculty of Health Studies
(Department of Basic Medical Sciences)
Scientific / art field,
discipline and subdiscipline		BIOTECHNICAL SCIENCES
Biotechnology
Molecular Biotechnology
Abstract (english)
The authors’ aim was to improve the application of copper-catalyzed azide-alkyne cycloaddition in the synthesis of hybrids containing biologically significant nucleobases and L-ascorbic acid scaffolds by introducing an environmentally friendly and waste-free ball mill. Results: Two series of hybrids with a purine, pyrrolo[2,3-d]pyrimidine or 5-substituted pyrimidine attached to 2,3-dibenzyl-L-ascorbic acid via a hydroxyethyl- (15a–23a) or ethylidene-1,2,3-triazolyl (15b–23b) bridge were prepared by ball milling and conventional synthesis. The unsaturated 6-chloroadenine L-ascorbic acid derivative 16b can be highlighted as a lead compound and showed strong antiproliferative activity against HepG2 (hepatocellular carcinoma) and SW620 (colorectal adenocarcinoma) cells. Conclusion: Mechanochemical synthesis was superior in terms of sustainability, reaction rate and yield, highlighting the advantageous applications of ball milling over classical reactions.
Keywords (english)
Languageenglish
Publication typeScientific paper - Original scientific paper
Publication statusPublished
Peer reviewPeer review
Publication versionPublished version
Journal titleFuture Med. Chem.
Numberingvol. 14, no. 16, pp. 1187-1202
p-ISSN1756-8919
DOIhttps://doi.org/10.4155/fmc-2022-0047
URN:NBNurn:nbn:hr:184:144906
Publication2022
Type of resourceText
Access conditionsOpen access
Terms of useLicence In copyright icon
Created on2023-01-30 13:26:12